Sign In
Buy ARDS
$0.0029
+0 (+0%)
At Close: Jun 03, 2026
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novan (NOVN
Aridis Pharmaceuticals to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
09:30am, Friday, 26'th Jun 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, toda
Aridis Pharmaceuticals (ARDS) Gets a Buy Rating from Northland Securities - Markets
01:21pm, Monday, 22'nd Jun 2020
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on Aridis Pharmaceuticals (ARDS – Research
Nabriva (NBRV) Gets a Buy Rating from Northland Securities - Markets
11:03am, Monday, 22'nd Jun 2020
Northland Securities analyst Carl Byrnes maintained a Buy rating on Nabriva (NBRV – Research Report) today and set a price
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics
Aridis Reports AR-501 Clinical Data: Positive Safety Data in Healthy Subjects of a Phase 1/2a Clinical Trial
09:30am, Monday, 22'nd Jun 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced toda
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
12:00am, Sunday, 21'st Jun 2020
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...
Xconomy: Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More
03:33pm, Friday, 19'th Jun 2020
The biggest life sciences deal this week involves a company that doesn’t discover or develop drugs, or even sell them. Yet its mark is found on
Aridis Pharmaceuticals to Discuss APEX™ in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
09:30am, Thursday, 18'th Jun 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, anno
Bose gives up on its augmented reality sound project
08:52pm, Tuesday, 16'th Jun 2020
A tough year for Bose
Northland Securities Reaffirms Their Buy Rating on vTv Therapeutics (VTVT) - Markets
10:56am, Monday, 15'th Jun 2020
In a report released today, Carl Byrnes from Northland Securities maintained a Buy rating on vTv Therapeutics (VTVT – Research
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
09:30am, Monday, 15'th Jun 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, anno
Healthcare Administrative Partners & Strategic Radiology–PSO Collaborate on Incidental Findings Communication
12:00am, Thursday, 14'th May 2020
Healthcare Administrative Partners (HAP), a comprehensive radiology revenue cycle management solutions provider, today announces their partnership wit
Aridis Pharmaceuticals Announces First Quarter 2020 Results
08:05pm, Tuesday, 12'th May 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, toda
Bakkafrost's (BKFKF) CEO Regin Jacobsen on Q1 2020 Results - Earnings Call Transcript
06:07pm, Sunday, 10'th May 2020
Bakkafrost PF (OTCPK:BKFKF) Q1 2020 Earnings Conference Call May 05, 2020 02:00 AM ET Company Participants Regin Jacobsen – Chief Executive Officer Høgni Jakobs
